Searched for
PHARMEASY LOAN BREACH
Byju’s FY22 losses soar to Rs 8,245 crore; cash-strapped edtech explores rights issue at $500 million valuationThe rights issue, where existing investors will be offered the option to buy new shares in Think & Learn, may value the edtech firm at anyw...- Ranjan Pai cuts Rs 1,400 crore cheque for Davidson Kempner debt, books Aakash seatsIn May, Byju’s had signed a Rs 2,000-crore ($240 million) structured credit deal with Davidson Kempner against the cash flows of Aakash Ins...
- Manipal group's Ranjan Pai likely to invest $250-300 million in Byju's subsidiary Aakash InstituteThe initial $170 million tranche will pay off Davidson Kempner debt; the Manipal chairman may rope in more PEs.
- How digital payments became democratic – the UPI way, and other top tech & startup stories this weekUnified Payments Interface (UPI), the real-time bank transfer mechanism, breached the 10 billion monthly transaction volume mark last month...
- Goldman may convert part-debt into equity in PharmEasyThe online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4
- Goldman may part-convert Pharmeasy debt to equity; P2P lenders look to diversify partnershipsGoldman Sachs is likely to convert some of its loan to online pharmacy PharmEasy into equity. Buoyed by binding commitments from existing i...
- ETtech Explainer: What are down rounds and will they become the norm for Indian startups?A down round is when a privately held firm raises funds at a valuation lower than that ascribed in the previous round.
- Till debt do us part: will startups go the PharmEasy way, and other top tech & startup stories this weekThis week’s ETtech newsbreak on PharmEasy going for a rights issue at a price 90% lower than its peak valuation of $5.6 billion to repay de...
- PharmEasy parent seeks shareholder nod to increase authorised share capitalThe board notified its shareholders about increasing the authorised share capital to Rs 3,500 crore (about $423.72 million), divided into 3...
- Exclusive: PharmEasy plans Rs 2,400-crore rights issue at 90% discount to repay loanMumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021
- PharmEasy SOS: plans rights issue at 90% discount to repay loan; Cabinet approves Digital Personal Data billThe online drugstore plans to swallow a bitter pill in the hope that it can heal itself. The distress rights issue, if it goes through, wil...
- PharmEasy plans rights issue at 90% valuation cut; Amazon set to hit $8B India exportsEarlier in the day we broke the news that PharmEasy’s investors have taken control of the company as they plan a Rs 2,400 crore rights issu...
- Byju's and the debt trap haunting Indian tech startupsLoss-making startups taking on debt is a sure-shot recipe for disaster, said a founder who has seen several funding cycles. “In the era of ...
- What is really happening with digital credit in India, and other top stories this weekThe aftermath of Covid-19 and the subsequent moratorium on loan repayments burnt a massive hole in the loan books of lenders. While the lar...
- India’s emerging as next chip-making destination: Ashwini Vaishnaw; VCs reach out to CBDT on angel taxHappy Friday! Union IT minister Ashwini Vaishnaw told ET in an interview that some major players expect India to be the next chip-making de...
- Byju’s lenders scrap talks to recast $1.2B loan; Janus Henderson cuts PharmEasy valuation furtherByju’s woes seem to have no end. The company has suffered a series of setbacks over the last year, including ED raids and valuation markdow...
- Global asset manager Janus Henderson cuts PharmEasy valuation further to $2.7 billionAs of March 31, 2023, funds managed by Janus Henderson valued their stake in the startup at $2.7 billion – less than half of the $5.6 billi...
- PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loanPharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...
- Apple India stores post record sales; PharmEasy breaches loan covenant; and Amazon’s ten-year India rideWe are already in June, the year is racing past. Hope you have an interesting summer planned ahead. In April, Apple opened two company-owne...
- Slice alters business model; SoftBank, Sequoia want firms to join ONDCThe new rule has forced Slice, which until now offered a revolving credit line to customers, to alter its business model.
Load More
